Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date (Ascending) Package Discontinuation Date Status
00013-2200-01 00013-2200 Idarubicin Hydrochloride Idamycin PFS Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 1997 June 1, 2010 No Longer Used
00013-2202-01 00013-2202 Idarubicin Hydrochloride Idamycin PFS Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 1997 June 1, 2010 No Longer Used
00013-2586-91 00013-2586 Idarubicin Hydrochloride Idamycin PFS 1.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 1997 In Use
00013-2596-91 00013-2596 Idarubicin Hydrochloride Idamycin PFS 1.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 1997 In Use
99207-0260-01 99207-0260 Imiquimod Aldara 50.0 mg/g Immunotherapy Immunomodulator Dermatological Agent Topical Feb. 27, 1997 Dec. 31, 2015 No Longer Used
99207-0260-12 99207-0260 Imiquimod Aldara 50.0 mg/g Immunotherapy Immunomodulator Dermatological Agent Topical Feb. 27, 1997 June 30, 2022 No Longer Used
55513-0823-01 55513-0823 Epoetin alfa Epogen Ancillary Therapy Erythropoiesis-Stimulating Agent March 3, 1997 July 31, 2010 No Longer Used
55513-0823-10 55513-0823 Epoetin alfa Epogen Ancillary Therapy Erythropoiesis-Stimulating Agent March 3, 1997 July 31, 2010 No Longer Used
55513-0478-01 55513-0478 Epoetin alfa Epogen 20000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous March 3, 1997 In Use
55513-0478-10 55513-0478 Epoetin alfa Epogen 20000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous March 3, 1997 In Use
54092-0064-01 54092-0064 Anagrelide Agrylin Ancillary Therapy Platelet-Reducing Agent PDE-3 Inhibitor Oral March 14, 1997 March 31, 2008 No Longer Used
54092-0063-01 54092-0063 Anagrelide hydrochloride Agrylin 0.5 mg/1, 0.5 mg/1 Ancillary Therapy Platelet-Reducing Agent PDE-3 Inhibitor Oral March 14, 1997 In Use
55513-0546-01 55513-0546 Filgrastim Neupogen 480.0 ug/1.6mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous April 7, 1997 In Use
55513-0546-10 55513-0546 Filgrastim Neupogen 480.0 ug/1.6mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous April 7, 1997 In Use
00703-5657-01 00703-5657 Etoposide Toposar 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous May 1, 1997 Aug. 31, 2022 In Use
57902-0860-03 57902-0860 Samarium SM 153 Lexidronam Quadramet 50.0 mCi/mL Ancillary Therapy Radiopharmaceutical Samarium Sm 153 Intravenous May 19, 1997 In Use
55513-0530-01 55513-0530 Filgrastim Neupogen 300.0 ug/mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous May 19, 1997 In Use
55513-0530-10 55513-0530 Filgrastim Neupogen 300.0 ug/mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous May 19, 1997 In Use
11994-0016-01 11994-0016 samarium Sm 153 lexidronam Quadramet 50.0 mCi/mL Ancillary Therapy Radiopharmaceutical Samarium Sm 153 Intravenous May 19, 1997 In Use
00703-5145-01 00703-5145 Leucovorin Calcium Leucovorin Calcium 350.0 mg/17.5mL Ancillary Therapy Chemoprotective Antidote Intramuscular, Intravenous June 12, 1997 Sept. 30, 2023 No Longer Used
11399-0005-01 11399-0005 Toremifene Citrate Fareston 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 30, 1997 April 30, 2016 No Longer Used
11399-0005-07 11399-0005 Toremifene Citrate Fareston 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 30, 1997 April 30, 2016 No Longer Used
11399-0005-30 11399-0005 Toremifene Citrate Fareston 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 30, 1997 April 30, 2016 No Longer Used
42747-0327-07 42747-0327 Toremifene Citrate Fareston 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 30, 1997 Oct. 27, 2016 In Use
42747-0327-30 42747-0327 Toremifene Citrate Fareston 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 30, 1997 In Use
42747-0327-72 42747-0327 Toremifene Citrate Fareston 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 30, 1997 In Use
00078-0249-15 00078-0249 Letrozole Femara 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral July 31, 1997 In Use
51079-0434-01 51079-0434 Megestrol Acetate Megestrol Acetate 20.0 mg/1 Hormonal Therapy Progestin Analog Oral Aug. 7, 1997 March 31, 2021 No Longer Used
51079-0434-20 51079-0434 Megestrol Acetate Megestrol Acetate 20.0 mg/1 Hormonal Therapy Progestin Analog Oral Aug. 7, 1997 March 31, 2021 No Longer Used
51079-0582-01 51079-0582 Leucovorin Calcium Leucovorin Calcium 25.0 mg/1 Ancillary Therapy Chemoprotective Antidote Oral Aug. 27, 1997 No Longer Used
51079-0582-05 51079-0582 Leucovorin Calcium Leucovorin Calcium 25.0 mg/1 Ancillary Therapy Chemoprotective Antidote Oral Aug. 27, 1997 June 30, 2023 No Longer Used
54868-4138-00 54868-4138 Dolasetron mesylate Anzemet Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 June 30, 2010 No Longer Used
54868-4138-01 54868-4138 Dolasetron mesylate Anzemet Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 June 30, 2010 No Longer Used
00088-1202-05 00088-1202 Dolasetron mesylate Anzemet 50.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 June 30, 2017 No Longer Used
00088-1202-43 00088-1202 Dolasetron mesylate Anzemet 50.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 Aug. 31, 2011 No Longer Used
00088-1203-05 00088-1203 Dolasetron mesylate Anzemet 100.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 June 30, 2017 No Longer Used
00088-1203-29 00088-1203 Dolasetron mesylate Anzemet 100.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 March 31, 2006 No Longer Used
00088-1203-43 00088-1203 Dolasetron mesylate Anzemet 100.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 Oct. 31, 2012 No Longer Used
00088-1206-32 00088-1206 Dolasetron mesylate Anzemet 100.0 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sept. 11, 1997 Sept. 30, 2017 No Longer Used
00088-1208-06 00088-1208 Dolasetron mesylate Anzemet 12.5 mg/.625mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sept. 11, 1997 Aug. 31, 2016 No Longer Used
00088-1208-76 00088-1208 Dolasetron mesylate Anzemet 12.5 mg/.625mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sept. 11, 1997 Nov. 9, 2012 No Longer Used
00088-1209-26 00088-1209 Dolasetron mesylate Anzemet 500.0 mg/25mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sept. 11, 1997 June 30, 2016 No Longer Used
30698-0120-05 30698-0120 Dolasetron mesylate Anzemet 50.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 May 24, 2021 In Use
30698-0121-05 30698-0121 Dolasetron mesylate Anzemet 100.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Sept. 11, 1997 May 24, 2021 In Use
16590-0052-71 16590-0052 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Oct. 22, 1997 In Use
51079-0435-01 51079-0435 Megestrol Acetate Megestrol Acetate Hormonal Therapy Progestin Analog Oral Oct. 23, 1997 Jan. 31, 2015 No Longer Used
51079-0435-20 51079-0435 Megestrol Acetate Megestrol Acetate Hormonal Therapy Progestin Analog Oral Oct. 23, 1997 Jan. 31, 2015 No Longer Used
00555-0899-02 00555-0899 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
54569-4907-00 54569-4907 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
54569-4907-02 54569-4907 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
54569-4908-00 54569-4908 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
33261-0667-30 33261-0667 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
33261-0667-60 33261-0667 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
00555-0886-01 00555-0886 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Jan. 26, 2011 In Use
00555-0886-02 00555-0886 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
00555-0886-04 00555-0886 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
00555-0886-14 00555-0886 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Jan. 26, 2011 In Use
66267-0093-30 66267-0093 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Dec. 13, 2018 No Longer Used
66267-0093-60 66267-0093 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Dec. 13, 2018 No Longer Used
66267-0093-91 66267-0093 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Dec. 13, 2018 No Longer Used
00555-0887-01 00555-0887 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Jan. 26, 2011 In Use
00555-0887-02 00555-0887 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
00555-0887-04 00555-0887 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
00555-0887-14 00555-0887 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 Jan. 26, 2011 In Use
33261-0714-60 33261-0714 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
16590-0149-21 16590-0149 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
42549-0522-21 42549-0522 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
54569-8856-00 54569-8856 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
59746-0001-03 59746-0001 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
59746-0001-06 59746-0001 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
59746-0002-04 59746-0002 Methylprednisolone Methylprednisolone 8.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
59746-0002-06 59746-0002 Methylprednisolone Methylprednisolone 8.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
59746-0003-14 59746-0003 Methylprednisolone Methylprednisolone 16.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
59746-0015-04 59746-0015 Methylprednisolone Methylprednisolone 32.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
63629-3910-01 63629-3910 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
21695-0080-21 21695-0080 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 In Use
33261-0335-21 33261-0335 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 No Longer Used
00781-5022-01 00781-5022 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 Jan. 31, 2024 No Longer Used
00781-5022-07 00781-5022 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 April 30, 2023 No Longer Used
00781-5022-10 00781-5022 Methylprednisolone Methylprednisolone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 31, 1997 Oct. 31, 1997 No Longer Used
50242-0051-21 50242-0051 Rituximab Rituxan 10.0 mg/mL Immunotherapy Monoclonal Antibody CD20 Intravenous Nov. 26, 1997 In Use
50242-0053-06 50242-0053 Rituximab Rituxan 10.0 mg/mL Immunotherapy Monoclonal Antibody CD20 Intravenous Nov. 26, 1997 In Use
00002-4165-02 00002-4165 Raloxifene Hydrochloride Evista 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 6, 1998 Dec. 31, 2017 No Longer Used
00002-4165-07 00002-4165 Raloxifene Hydrochloride Evista 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 6, 1998 Nov. 30, 2017 No Longer Used
00002-4165-30 00002-4165 Raloxifene Hydrochloride Evista 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 6, 1998 Jan. 31, 2018 No Longer Used
00002-4165-34 00002-4165 Raloxifene Hydrochloride Evista 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 6, 1998 Jan. 25, 2011 No Longer Used
00002-4165-79 00002-4165 Raloxifene Hydrochloride Evista 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 6, 1998 Jan. 25, 2011 No Longer Used
00781-5325-01 00781-5325 Bromocriptine Mesylate Bromocriptine Mesylate 2.5 mg/1 Chemotherapy Dopamine Agonist Ergot Derivative Oral Jan. 13, 1998 In Use
00781-5325-31 00781-5325 Bromocriptine Mesylate Bromocriptine Mesylate 2.5 mg/1 Chemotherapy Dopamine Agonist Ergot Derivative Oral Jan. 13, 1998 In Use
00004-1100-20 00004-1100 Capecitabine Xeloda 150.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral April 30, 1998 In Use
00004-1100-75 00004-1100 Capecitabine Xeloda 150.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral April 30, 1998 Dec. 31, 2014 In Use
00004-1101-50 00004-1101 Capecitabine Xeloda 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral April 30, 1998 In Use
00004-1101-75 00004-1101 Capecitabine Xeloda 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral April 30, 1998 Dec. 31, 2014 In Use
00944-2620-01 00944-2620 Human Immunoglobulin G GAMMAGARD Ancillary Therapy Immunostimulant Human Immunoglobulin G May 1, 1998 May 1, 1998 In Use
55390-0108-01 55390-0108 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 1, 1998 Sept. 30, 2013 No Longer Used
55390-0108-10 55390-0108 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 1, 1998 Sept. 30, 2013 No Longer Used
55390-0142-10 55390-0142 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous July 13, 1998 Oct. 31, 2012 No Longer Used
00781-4003-32 00781-4003 Leuprolide Acetate Leuprolide Acetate Hormonal Therapy GnRH Agonist Aug. 4, 1998 In Use
00185-7400-85 00185-7400 Leuprolide Acetate Leuprolide Acetate 1.0 mg/.2mL Hormonal Therapy GnRH Agonist Subcutaneous Aug. 4, 1998 In Use
00703-5075-01 00703-5075 Dacarbazine Dacarbazine 200.0 mg/20mL Chemotherapy Alkylating Agent Purine Analog Intravenous Aug. 27, 1998 May 31, 2024 In Use

Found 10,000 results in 8 millisecondsExport these results